Serial measurements of high sensitive cardiac troponin I in patients with acutely decompensated heart failure treated with carperitide or nitrates

Journal of Cardiology - Tập 56 - Trang 66-72 - 2010
Yukihito Sato1, Kiyoto Nishi1, Sayaka Saijo1, Yohei Tanada1, Taisuke Goto1, Naoki Takahashi1, Erika Yamamoto1, Rei Fukuhara1, Tadashi Miyamoto1, Ryoji Taniguchi1, Hisayoshi Fujiwara1, Yoshiki Takatsu1
1Department of Cardiology, Hyogo Prefectural Amagasaki Hospital, Higashidaimotsucho 1-1-1, Amagasaki, Hyogo 660-0828, Japan

Tài liệu tham khảo

Jessup, 2003, Heart failure, N Engl J Med, 348, 2007, 10.1056/NEJMra021498 McMurray, 2005, Heart failure, Lancet, 365, 1877, 10.1016/S0140-6736(05)66621-4 Gheorghiade, 2005, Pathophysiologic targets in the early phase of acute heart failure syndromes, Am J Cardiol, 96, 11G, 10.1016/j.amjcard.2005.07.016 Gheorghiade, 2009, Acute heart failure syndromes, J Am Coll Cardiol, 53, 557, 10.1016/j.jacc.2008.10.041 O’Connor, 1999, Continuous intravenous dobutamine is associated with an increased risk of death in patients with advanced heart failure: insights from the Flolan International Randomized Survival Trial (FIRST), Am Heart J, 138, 78, 10.1016/S0002-8703(99)70250-4 Cuffe, 2002, Outcomes of a Prospective Trial of Intravenous Milrinone for Exacerbations of Chronic Heart Failure (OPTIME-CHF) Investigators. Short-term intravenous milrinone for acute exacerbation of chronic heart failure: a randomized controlled trial, JAMA, 287, 1541, 10.1001/jama.287.12.1541 Abraham, 2005, J Am Coll Cardiol, 46, 57, 10.1016/j.jacc.2005.03.051 Task Force for Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of European Society of Cardiology, 2008, Eur Heart J, 29, 2388, 10.1093/eurheartj/ehn309 Hunt, 2009, Circulation, 119, e391, 10.1161/CIRCULATIONAHA.109.192065 Morrow, 2007, National Academy of Clinical Biochemistry. National Academy of Clinical Biochemistry Laboratory Medicine Practice Guidelines: clinical characteristics and utilization of biochemical markers in acute coronary syndromes, Circulation, 115, e356, 10.1161/CIRCULATIONAHA.107.182882 Tang, 2007, National Academy of Clinical Biochemistry Laboratory Medicine. National Academy of Clinical Biochemistry Laboratory Medicine practice guidelines: clinical utilization of cardiac biomarker testing in heart failure, Circulation, 116, e99, 10.1161/CIRCULATIONAHA.107.185267 Sato, 2001, Persistently increased serum concentrations of cardiac troponin T in patients with idiopathic dilated cardiomyopathy are predictive of adverse outcomes, Circulation, 103, 369, 10.1161/01.CIR.103.3.369 Sato, 2009, In patients with heart failure and non-ischemic heart disease, cardiac troponin T is a reliable predictor of long-term echocardiographic changes and adverse cardiac events, J Cardiol, 54, 221, 10.1016/j.jjcc.2009.05.007 Latini, 2007, Val-HeFT Investigators. Prognostic value of very low plasma concentrations of troponin T in patients with stable chronic heart failure, Circulation, 116, 1242, 10.1161/CIRCULATIONAHA.106.655076 Sato, 2002, Serum cardiac troponin T and plasma brain natriuretic peptide in patients with cardiac decompensation, Heart, 88, 647, 10.1136/heart.88.6.647 Peacock, 2008, ADHERE investigators. Cardiac troponin and outcome in acute heart failure, N Engl J Med, 358, 2117, 10.1056/NEJMoa0706824 Kuwabara, 2007, Persistently increased serum concentrations of cardiac troponin in patients with acutely decompensated heart failure are predictive of adverse outcomes, Circ J, 71, 1047, 10.1253/circj.71.1047 Sato, 2008, Malignant link between chronic heart failure and acute cardiac decompensation in patients with persistently increased serum concentrations of cardiac troponin, Int J Cardiol, 126, 171, 10.1016/j.ijcard.2007.08.053 Miller, 2005, Biomarker responses during and after treatment with nesiritide infusion in patients with decompensated chronic heart failure, Clin Chem, 51, 569, 10.1373/clinchem.2004.041582 Saito, 1987, Clinical application of atrial natriuretic polypeptide in patients with congestive heart failure: beneficial effects on left ventricular function, Circulation, 76, 115, 10.1161/01.CIR.76.1.115 Nomura, 2008, Circ J, 72, 1777, 10.1253/circj.CJ-07-0760 Kimura, 2007, ANP is cleared much faster than BNP in patients with congestive heart failure, Eur J Clin Pharmacol, 63, 699, 10.1007/s00228-007-0309-1 Cotter, 1998, Randomised trial of high-dose isosorbide dinitrate plus low-dose furosemide versus high-dose furosemide plus low-dose isosorbide dinitrate in severe pulmonary oedema, Lancet, 351, 389, 10.1016/S0140-6736(97)08417-1 Sharon, 2000, High-dose intravenous isosorbide-dinitrate is safer and better than Bi-PAP ventilation combined with conventional treatment for severe pulmonary edema, J Am Coll Cardiol, 36, 832, 10.1016/S0735-1097(00)00785-3 Apple, 2009, A new season for cardiac troponin assays: it's time to keep a scorecard, Clin Chem, 55, 1303, 10.1373/clinchem.2009.128363 Nishio, 2007, Cardiac troponin T vs other biochemical markers in patients with congestive heart failure, Circ J, 71, 631, 10.1253/circj.71.631 Johnson, 2002, Neurohormonal activation rapidly decreases after intravenous therapy with diuretics and vasodilators for class IV heart failure, J Am Coll Cardiol, 39, 1623, 10.1016/S0735-1097(02)01814-4 Milo, 2003, Comparison of inflammatory and neurohormonal activation in cardiogenic pulmonary edema secondary to ischemic versus nonischemic causes, Am J Cardiol, 92, 222, 10.1016/S0002-9149(03)00545-9 Publication Committee for the VMAC Investigators (Vasodilatation in the Management of Acute CHF), 2002, Intravenous nesiritide vs nitroglycerin for treatment of decompensated congestive heart failure: a randomized controlled trial, JAMA, 287, 1531 Sackner-Bernstein, 2005, Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure, Circulation, 111, 1487, 10.1161/01.CIR.0000159340.93220.E4 Biolo, 2010, Episodes of acute heart failure syndrome are associated with increased levels of troponin and extracellular matrix markers, Circ Heart Fail, 3, 44, 10.1161/CIRCHEARTFAILURE.108.844324 Sato, 2009, The clinical and hemodynamic factors that influence the concentrations of biomarkers of myocyte injury measured by high sensitive assay PATHFAST, J Cardiol, 53, 20, 10.1016/j.jjcc.2008.08.004 Wu, 2009, Short- and long-term biological variation in cardiac troponin I measured with a high-sensitivity assay: implications for clinical practice, Clin Chem, 55, 52, 10.1373/clinchem.2008.107391